What I did was an assumption of MINIMUM SALES from given data for Q2, not saying it would be $1.426m
So, as a growth company, if anything was better than last year which it should be, we should get a sales figure greater than $1.426m in Q2
that's even without any further sales on the COVID side, if we sold some antigen tests or antibody tests in Australia which was not significant enough to announce to the market would contribute too
And with the HIV side of the business, John said in a webinar that HIV business was sidetracked because of the COVID situation and they were gonna focus a bit more on HIV this year
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-629
-
- There are more pages in this discussion • 1,805 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $1.244K | 61.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1627919 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 152000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1627919 | 0.020 |
4 | 765000 | 0.019 |
4 | 462414 | 0.018 |
3 | 65000 | 0.017 |
3 | 333328 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 152000 | 2 |
0.022 | 53184 | 2 |
0.023 | 200000 | 1 |
0.024 | 113559 | 2 |
0.025 | 29000 | 2 |
Last trade - 15.45pm 09/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |